Xarelto was designed as a replacement for a decades old blood thinner, warfarin, and was approved by the US Food and Drug Administration (FDA) in 2011.
The mass tort has combined lawsuits that contain related legal and factual issues concerning the safety of the drug. This mass tort is the first new one created in Philadelphia since the February 2014 establishment of a program for pelvic mesh suits. Lawyers representing the Xarelto plaintiffs expect to see many more lawsuits filed over the coming months.
READ MORE Xarelto LEGAL NEWS
Xarelto has reportedly been linked to an increased risk of uncontrollable bleeding (hemorrhaging). A risk of hemorrhaging exists in many blood thinners; however, warfarin has an antidote in that can reduce the risk of uncontrollable hemorrhaging. Some newer blood thinners do not have an antidote. This means that injuries, including minor cuts or internal bleeding, can result in uncontrolled bleeding, which can be fatal.